Reversing pancreatic cancer immunosuppression through pharmacological targeting of activated pancreatic stellate cells

Corinne Bousquet (1) , Rémi Samain (2) , Julia Rochotte , Stéphanie Cassant-Sourdy (3) , Herbert Schmid (4) , Aurélie Perraud (5, 6) , Muriel Mathonnet (6) , Yvan Martineau (1) , Stephane Pyronnet (1) , Christine Jean (1)

1 CRCT - Centre de Recherches en Cancérologie de Toulouse
2 UGA UFRP - Université Grenoble Alpes - UFR Pharmacie
3 I2MC - Institut des Maladies Métaboliques et Cardiovasculaires
4 Novartis Pharmaceuticals
5 HCP - Homéostasie Cellulaire et Pathologies
6 Service de Chirurgie digestive, endocrinienne et générale [CHU Limoges]

Domaines: Sciences du Vivant [q-bio]; Cancer

Corinne Bousquet, Rémi Samain, Julia Rochotte, Stéphanie Cassant-Sourdy, Herbert Schmid, et al.. Reversing pancreatic cancer immunosuppression through pharmacological targeting of activated pancreatic stellate cells. Pancreatology, 2017, 17 (3), pp.S44-S45. ⟨10.1016/j.pan.2017.05.139⟩. ⟨hal-02421424⟩